Peripheral Neuropathy (Sensory Neuropathy):グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Peripheral Neuropathy (Sensory Neuropathy) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 21
Clinical Trials in E7 Nations by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Unaccomplished Trials of Peripheral Neuropathy (Sensory Neuropathy) 26
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
NeurogesX, Inc. 37
Clinical Trial Overview of NeurogesX, Inc. 37
GW Pharmaceuticals plc 38
Clinical Trial Overview of GW Pharmaceuticals plc 38
Johnson & Johnson 39
Clinical Trial Overview of Johnson & Johnson 39
CSL Behring LLC 40
Clinical Trial Overview of CSL Behring LLC 40
Origin BioMed, Inc. 41
Clinical Trial Overview of Origin BioMed, Inc. 41
Endo Pharmaceuticals Inc. 42
Clinical Trial Overview of Endo Pharmaceuticals Inc. 42
Protemix Corporation Limited 43
Clinical Trial Overview of Protemix Corporation Limited 43
Neurotune AG 44
Clinical Trial Overview of Neurotune AG 44
Eisai Inc. 45
Clinical Trial Overview of Eisai Inc. 45
Lupin Limited 46
Clinical Trial Overview of Lupin Limited 46
Merck KGaA 47
Clinical Trial Overview of Merck KGaA 47
Sigma-Tau S.p.A. 48
Clinical Trial Overview of Sigma-Tau S.p.A. 48
Bristol-Myers Squibb Company 49
Clinical Trial Overview of Bristol-Myers Squibb Company 49
Octapharma AG 50
Clinical Trial Overview of Octapharma AG 50
Laboratorios Del Dr. Esteve S.A. 51
Clinical Trial Overview of Laboratorios Del Dr. Esteve S.A. 51
Cubist Pharmaceuticals, Inc. 52
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 52
Astellas Pharma Inc. 53
Clinical Trial Overview of Astellas Pharma Inc. 53
Grifols, S.A. 54
Clinical Trial Overview of Grifols, S.A. 54
Otsuka Pharmaceutical Co., Ltd. 55
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 55
Clinical Trial Overview of Top Institutes / Government 56
The University of Texas M. D. Anderson Cancer Center 56
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 56
Odense University Hospital 57
Clinical Trial Overview of Odense University Hospital 57
National Taiwan University Hospital 58
Clinical Trial Overview of National Taiwan University Hospital 58
The National Institute of Allergy and Infectious Diseases 59
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 59
National Center for Research Resources 60
Clinical Trial Overview of National Center for Research Resources 60
Washington University School of Medicine 61
Clinical Trial Overview of Washington University School of Medicine 61
Northwestern University 62
Clinical Trial Overview of Northwestern University 62
Erasmus MC 63
Clinical Trial Overview of Erasmus MC 63
Mayo Clinic 64
Clinical Trial Overview of Mayo Clinic 64
Johns Hopkins University 65
Clinical Trial Overview of Johns Hopkins University 65
Assistance Publique – Hopitaux de Paris 66
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 66
The University of Auckland 67
Clinical Trial Overview of The University of Auckland 67
U.S. Department of Veterans Affairs 68
Clinical Trial Overview of U.S. Department of Veterans Affairs 68
National Center for Complementary and Alternative Medicine 69
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 69
Oregon Health and Science University 70
Clinical Trial Overview of Oregon Health and Science University 70
Columbia University 71
Clinical Trial Overview of Columbia University 71
Virginia Commonwealth University 72
Clinical Trial Overview of Virginia Commonwealth University 72
Skane University Hospital 73
Clinical Trial Overview of Skane University Hospital 73
National Institute of Neurological Disorders and Stroke 74
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 74
H. Lee Moffitt Cancer Center & Research Institute 75
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 75
Five Key Clinical Profiles 76
Appendix 200
Abbreviations 200
Definitions 200
Research Methodology 201
Secondary Research 201
About GlobalData 202
Contact Us 202
Disclaimer 202
Source 203


【レポート販売概要】

■ タイトル:Peripheral Neuropathy (Sensory Neuropathy):グローバル臨床試験レビューH1, 2013
■ 英文:Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013
■ 発行日:2013年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161286
■ 調査対象地域:グローバル
  • Endeavour International Corporation:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Endeavour International Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Endeavour International Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The r …
  • GoogleSMS: Technology Migration from the First World to the Third World using a Low Cost? No Cost Corporate Social Responsibility Model
    The low cost evidenced by the GoogleSMS model is interpreted as being indicative of the low cost involved in “testing” the Third World market. This is construed to imply the idea is tenable and companies have a “built-in” opening to affect consumer behavior as it takes shape around solutions they create to take advantage of the largely “uncharted waters” in the innovation space. As the GoogleSMS e …
  • 世界のMES市場動向(2012-2016)
    TechNavio's analysts forecast the Global MES market to grow at a CAGR of 11.71 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to improve the decision-making system. The Global MES market has also been witnessing the development of web-based MES solutions. However, the reluctance in migrating to the latest technology could pose a challenge t …
  • Luliconazole (Dermatophytic Onychomycosis):市場予測と分析(~2022)
    Luliconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Luliconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022”. Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection can involve the nail unit (nail matrix, nail bed, or nai …
  • 業務用スキンケア製品の世界市場2017-2021
    About Professional Skincare Based on the target market and product pricing, the beauty products industry can be divided into two broad categories: mass beauty care and premium beauty care. While the mass category is targeted at the middle- and lower-income class (C, C-/D+, and D/E class) population, the premium category is targeted at the upper-income class (A/B and C+) or affluent class of the po …
  • BaaS(バイオメトリクスサービス)の世界市場2016-2020
    About Biometrics as a Service In 1999, biometrics was introduced as an application to render authentication after identifying and verifying biological and physiological traits such as voice, palm geometry, DNA, gait, fingerprints, facial features, iris, signature, and vein geometry. This technology is reliable, as it cannot be lost or forgotten by an individual. Verification is a one-to-one matchi …
  • 季節インフルエンザ・ワクチン:世界市場(医薬品市場予測及び分析~2022)
    PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update Summary Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such as fever, cold and cough. The market is heavily driven by the sales of prophylactic vaccine treatments to prevent infection. Currently, trivalent intramuscular v …
  • プロジェクト・ポートフォリオ管理(PPM)の世界市場予測・分析(~2020)
    The Project Portfolio Management (PPM) market size is expected to grow from USD 2.52 Billion in 2015 to USD 4.63 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 12.9%. With the increasing complexities in handling various projects and analyzing huge data, organizations would have a tough time maintaining efficient work pace, while optimizing all assets such as resource, time, and financ …
  • T-Cell Lymphomas:グローバル臨床試験動向(2014年上半期)
    T-Cell Lymphomas Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H1, 2014" provides data on the T-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment statu …
  • 仮想検査の世界市場2016-2020
    About Virtual Inspection Virtual inspection technologies represent a low-cost strategy that helps manufacturers achieve operational efficiency. Machine vision uses video cameras, analog-to-digital conversion, and digital signal processing technologies for application in surface defect detection, surface auto-vision, and AUVs. Keeping in view the evolution of technologies, we expect virtual inspect …
  • たばこ製造・販売企業分析:Organisation Generale de Tabacs
    Synopsis This report provides a unique and comprehensive analysis of the company Global, Regional and National Tobacco Players: Organisation Generale de Tabacs, including the corporate profile, organisation structure, financial data, and competitive positioning. The analysis also details the organisation's history, merger and acquisition activity, licensing agreements, brand portfolio, as well as …
  • 世界のタイヤコード市場2015
    The Global Tire Cord Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Tire Cord industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Tire Cord market analysis is provided for the international markets including development trends, competitive landscap …
  • 2014年戦略提言:イタリアの血液及びフローサイトメトリー市場
    Complete report $6,200.  DataPack (test volumes, sales forecasts, supplier shares) $3,900.SummaryThis comprehensive report contains 250 pages, 32 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in Italian hematology and flow cytometry markets during the next five years.  The report explores business and …
  • ミートフリー食品(肉代用食品)の世界市場:マイコプロテイン、ピー・プロテイン、豆腐、テンペ、TVP、セイタン
    Visiongain predicts the world meat-free foods market will reach $3.86bn in 2015. Meat-free foods are one of the globally growing “free-from” trends that are being driven by the health concerns of society and the willingness of consumers to protect livestock. Visiongain has examined the meat-free foods market and identified the main driving forces, as well as focused on barriers in development of t …
  • 放射線撮影技術の世界市場:フィルムベース撮影、コンピュータ断層撮影、コンピュータX線撮影、直接撮影
    1 Introduction (Page No. – 1...
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。